Abbott Laboratories (ABT) Earnings History
Annual and quarterly earnings data from 1989 to 2024
Loading earnings history...
ABT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ABT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 50.8% | 16.3% | 31.9% |
| 2023 | 50.0% | 16.0% | 14.3% |
| 2022 | 51.1% | 19.2% | 15.9% |
| 2021 | 53.9% | 21.4% | 16.4% |
| 2020 | 50.2% | 15.3% | 13.0% |
Download Data
Export ABT earnings history in CSV or JSON format
Free sign-in required to download data
Abbott Laboratories (ABT) Earnings Overview
As of May 8, 2026, Abbott Laboratories (ABT) reported trailing twelve-month net income of $13.98B, reflecting +133.6% year-over-year growth. The company earned $7.99 per diluted share over the past four quarters, with a net profit margin of 31.9%.
Looking at the long-term picture, ABT's 5-year EPS compound annual growth rate (CAGR) stands at +30.0%, indicating exceptional earnings growth. The company achieved its highest annual net income of $13.40B in fiscal 2024, representing a new all-time high.
Abbott Laboratories maintains industry-leading profitability with a gross margin of 50.8%, operating margin of 16.3%, and net margin of 31.9%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including MDT ($4.61B net income, 13.9% margin), BSX ($2.89B net income, 14.4% margin), BDX ($1.14B net income, 7.7% margin), ABT has outperformed on profitability metrics. Compare ABT vs MDT →
ABT Earnings vs Peers
Earnings metrics vs comparable public companies
ABT Historical Earnings Data (1989–2024)
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $13.40B | +134.2% | $6.83B | $7.64 | 31.9% | 16.3% |
| 2023 | $5.72B | -17.5% | $6.43B | $3.27 | 14.3% | 16.0% |
| 2022 | $6.93B | -2.0% | $8.36B | $3.91 | 15.9% | 19.2% |
| 2021 | $7.07B | +57.3% | $9.20B | $3.94 | 16.4% | 21.4% |
| 2020 | $4.50B | +21.9% | $5.29B | $2.50 | 13.0% | 15.3% |
| 2019 | $3.69B | +55.7% | $4.59B | $2.06 | 11.6% | 14.4% |
| 2018 | $2.37B | +396.4% | $3.84B | $1.34 | 7.7% | 12.6% |
| 2017 | $477M | -65.9% | $1.97B | $0.27 | 1.7% | 7.2% |
| 2016 | $1.40B | -68.3% | $3.25B | $0.94 | 6.7% | 15.6% |
| 2015 | $4.42B | +93.7% | $2.95B | $2.94 | 21.7% | 14.5% |
Full ABT Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ABT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ABT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonABT — Frequently Asked Questions
Quick answers to the most common questions about buying ABT stock.
Is ABT growing earnings?
ABT EPS is $7.99, with earnings growth accelerating to +133.6%. This exceeds the 5-year CAGR of +30.0%. TTM net income reached $14.0B.
What are ABT's profit margins?
Abbott Laboratories net margin is +31.9%, with operating margin at +16.3%. Above-average margins indicate pricing power.
How consistent are ABT's earnings?
ABT earnings data spans 1989-2024. The accelerating earnings trend is +133.6% YoY. Historical data enables comparison across business cycles.